Cancer drug-discovery and screening specialist
Cancer Pharmacologist and HTS Scientist
The team uses advanced lab screening and genetic tools to find new drug targets and learn how cancer cells respond to treatments for people with cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-11180516 on NIH RePORTER |
What this research studies
At Vanderbilt this scientist runs automated chemical screens, CRISPR/siRNA functional genomics, and high-content imaging on cancer cell models to spot molecules and genes that affect tumor behavior. They work with Vanderbilt researchers to design assays, run large-scale screens of compound and gene libraries, and analyze the data to identify promising leads. Most work is lab-based using cell models and patient-derived samples rather than treating patients directly. The goal is to move lab discoveries toward new therapies and trials that could help people with cancer.
Who could benefit from this research
Good fit: Patients with cancer who provide tumor samples to Vanderbilt researchers or who enroll in related clinical studies could be connected to findings from this work.
Not a fit: People seeking direct treatment from this project may not benefit immediately, since it focuses on laboratory discovery rather than delivering therapies right away.
Why it matters
Potential benefit: If successful, this work could uncover new drug targets and lead to better, more effective cancer treatments.
How similar studies have performed: High-throughput screening and CRISPR-based functional genomics have previously identified drug targets and informed development of cancer therapies, though translating discoveries into approved treatments can take time.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Bauer, Joshua a. — Vanderbilt University
- Study coordinator: Bauer, Joshua a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.